Biophytis S.A.
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
ALBPS | PA
Overview
Corporate Details
- ISIN(s):
- FR0012816825 (+4 more)
- LEI:
- 9695008GIE061NBGU106
- Country:
- France
- Address:
- 14 AVENUE DE L'OPERA, 75001 PARIS
- Website:
- https://www.biophytis.com/en/
Description
Biophytis S.A. is a clinical-stage biotechnology company focused on developing therapeutics to slow degenerative processes associated with aging and improve longevity. The company's primary strategy is centered on treating diseases that impair mobility. Its lead drug candidate, BIO101, is being advanced in late-stage clinical development for multiple age-related conditions. A key program is the SARA Phase 3 trial, the first-ever pivotal study for the treatment of sarcopenia (age-related muscle loss). Additionally, BIO101 is being evaluated in the OBA Phase 2 clinical trial for addressing muscle wasting in patients with obesity. The company aims to preserve muscle function and enhance functional outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-11-15 08:00 |
Biophytis a déposé la demande d’IND auprès de la FDA pour démarrer le développe…
|
French | 171.7 KB | ||
| 2019-11-07 08:00 |
Biophytis to attend BIO-Europe® in Hamburg
|
English | 105.5 KB | ||
| 2019-11-07 08:00 |
Biophytis participe à la conférence BIO-Europe® à Hambourg
|
French | 146.5 KB | ||
| 2019-10-31 08:00 |
Biophytis Reports H1 2019 Financial Results and Provides Business Update
|
English | 292.3 KB | ||
| 2019-10-31 08:00 |
Biophytis publie ses résultats du 1er semestre 2019 et fait le point sur ses ac…
|
French | 320.1 KB | ||
| 2019-10-21 17:30 |
Biophytis to attend The Galien MedStartUp 2019 Event in New York
|
English | 102.5 KB | ||
| 2019-10-21 17:30 |
Biophytis annonce sa participation à la conférence « The Galien MedStartup 2019…
|
French | 151.8 KB | ||
| 2019-10-14 08:00 |
Biophytis to attend the European Large & MidCap Event in Paris
|
English | 101.5 KB | ||
| 2019-10-14 08:00 |
Biophytis annonce sa participation au European Large & MidCap Event à Paris
|
French | 143.7 KB | ||
| 2019-09-26 08:00 |
Biophytis to Present at the 15th International Congress of the European Geriatr…
|
English | 136.1 KB | ||
| 2019-09-26 08:00 |
Biophytis présente au 15ème congrès international de la Société européenne de m…
|
French | 150.5 KB | ||
| 2019-09-19 19:10 |
Biophytis to Present at 15th International Pharma Licensing Symposium in Paris
|
English | 120.2 KB | ||
| 2019-09-19 19:10 |
Biophytis participe au 15ème Symposium International des Licences Pharmaceutiqu…
|
French | 237.8 KB | ||
| 2019-08-23 08:00 |
Biophytis has signed €24m bond funding from Negma to continue the development o…
|
English | 186.7 KB | ||
| 2019-08-23 08:00 |
Biophytis a signé un financement obligataire de 24 M€ auprès de Negma pour pour…
|
French | 156.0 KB |
Automate Your Workflow. Get a real-time feed of all Biophytis S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biophytis S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biophytis S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-11-22 | N/A | Other | Buy | 8,443,190 | 79,365.99 EUR |
| 2020-12-16 | N/A | Other | Sell | 500,000 | 499,000.00 EUR |
| 2020-12-16 | N/A | Other | Other | 313,417 | N/A |
| 2020-04-30 | N/A | Other | Other | 2,955,701 | 177,342.06 EUR |
Peer Companies
